A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Arcus Biosciences Inc’s current trading price is -32.39% away from its 52-week high, while its distance from the 52-week low is 32.97%. The stock’s price range for this time frame has been between $12.95 and $25.47. The trading volume of the company’s shares in the Healthcare reached around 1.0 million for the day, which was evidently higher than the average daily volume of 0.88 million over the last three months.
Arcus Biosciences Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $25.47 on 08/23/23, while the lowest price during the same period was $12.95 on 11/13/23.
How Financial Performance Impacts Market Capitalization
Arcus Biosciences Inc (RCUS) has experienced a quarterly decline of -2.33% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.56B and boasts a workforce of 577 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 16.61, with a change in price of +1.04. Similarly, Arcus Biosciences Inc recorded 857,581 in trading volume during the last 100 days, posting a change of +6.43%.
How RCUS’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for RCUS stands at 0.26. Similarly, the long-term debt-to-equity ratio is also 0.24.
RCUS Stock Stochastic Average
Arcus Biosciences Inc’s raw stochastic average for the past 50 days is currently at 45.69%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 29.45%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 51.22% and 61.13%, respectively.
RCUS Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -9.84% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -16.29%. Over the past 30 days, the price of RCUS has fallen by 4.94%. And in the last five days, it has fallen by -9.42%.
